Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical EGF cream for prevention of EGFR inhibitor-induced skin toxicity
NCT03051880Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Randomised, double-blind trial of Repair Control EGF in acneiform eruption and paronychia, sponsored by The Catholic University of Korea. Primary endpoint: Change of acneiform eruption at 8 weeks. Status: unknown.
02
Drugs
Repair Control EGF
03
Conditions
acneiform eruptionparonychia
Beyond the preview
Go deeper on NCT03051880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03051880.